curvularin has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Y; Deng, ZS; Guo, J; Li, X; Liu, YX; Pan, LR; Tan, Y; Yu, XJ; Zhao, Q; Zhong, J | 1 |
| Erkel, G; Rudolph, K; Serwe, A | 1 |
2 other study(ies) available for curvularin and Breast Cancer
| Article | Year |
|---|---|
10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred BALB C; Mice, Nude; STAT3 Transcription Factor; Xenograft Model Antitumor Assays; Zearalenone | 2021 |
Inhibition of TGF-β signaling by the fungal lactones (S)-curvularin, dehydrocurvularin, oxacyclododecindione and galiellalactone.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Genes, Reporter; Hep G2 Cells; Humans; Lactones; Macrocyclic Compounds; Neovascularization, Physiologic; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Zearalenone | 2013 |